이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Raffles Medical Group 과거 수익 실적
과거 기준 확인 2/6
Raffles Medical Group은 연평균 17.7%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 증가했으며, 연간 15.1%였습니다. 매출은 연평균 10.8%의 비율로 증가했습니다. Raffles Medical Group의 자기자본이익률은 8.7%이고 순이익률은 12.7%입니다.
주요 정보
17.7%
수익 성장률
16.9%
EPS 성장률
| Healthcare 산업 성장 | 9.7% |
| 매출 성장률 | 10.8% |
| 자기자본 수익률 | 8.7% |
| 순이익 | 12.7% |
| 다음 실적 업데이트 | 29 Jul 2024 |
최근 과거 실적 업데이트
Recent updates
Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024
May 09
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024
Apr 25Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 10Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)
Nov 16Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price
Nov 03Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors
Aug 23The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising
Jul 24Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt
Jun 13A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)
May 30Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?
May 12Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038
May 01Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger
Mar 13Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)
Feb 14Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up
Dec 04Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?
Nov 21Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?
Oct 09Is Raffles Medical Group (SGX:BSL) A Risky Investment?
Sep 26The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising
Sep 01With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case
Aug 20Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
Jun 01Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028
May 02We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease
Apr 18Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement
Feb 21Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly
Oct 14Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
Oct 02At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?
Sep 21Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock
Aug 12Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital
Jul 01At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?
May 25Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?
Apr 05Returns On Capital At Raffles Medical Group (SGX:BSL) Paint A Concerning Picture
Mar 24Is Raffles Medical Group (SGX:BSL) Using Too Much Debt?
Mar 12Robust Earnings May Not Tell The Whole Story For Raffles Medical Group (SGX:BSL)
Feb 28Insider Buying: The Raffles Medical Group Ltd (SGX:BSL) Executive Chairman & CEO Just Bought S$1.5m Worth Of Shares
Feb 24What Is Raffles Medical Group Ltd's (SGX:BSL) Share Price Doing?
Feb 22수익 및 비용 분석
수익 및 비용 분석
Raffles Medical Group 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 31 Dec 23 | 708 | 90 | 142 | 0 |
| 30 Sep 23 | 747 | 117 | 123 | 0 |
| 30 Jun 23 | 730 | 144 | 0 | 0 |
| 31 Mar 23 | 749 | 144 | 3 | 0 |
| 31 Dec 22 | 825 | 143 | 110 | 0 |
| 30 Sep 22 | 808 | 124 | 62 | 0 |
| 30 Jun 22 | 791 | 104 | 13 | 0 |
| 31 Mar 22 | 758 | 94 | 10 | 0 |
| 31 Dec 21 | 725 | 84 | 7 | 0 |
| 30 Sep 21 | 698 | 86 | 7 | 0 |
| 30 Jun 21 | 671 | 88 | 7 | 0 |
| 31 Mar 21 | 619 | 77 | 7 | 0 |
| 31 Dec 20 | 568 | 66 | 7 | 0 |
| 30 Sep 20 | 541 | 60 | 9 | 0 |
| 30 Jun 20 | 508 | 50 | 8 | 0 |
| 31 Mar 20 | 514 | 55 | 9 | 0 |
| 31 Dec 19 | 522 | 60 | 10 | 0 |
| 30 Sep 19 | 514 | 63 | 14 | 0 |
| 30 Jun 19 | 504 | 66 | 16 | 0 |
| 31 Mar 19 | 497 | 69 | 15 | 0 |
| 31 Dec 18 | 489 | 71 | 20 | 0 |
| 30 Sep 18 | 484 | 71 | 18 | 0 |
| 30 Jun 18 | 483 | 71 | 17 | 0 |
| 31 Mar 18 | 483 | 71 | 16 | 0 |
| 31 Dec 17 | 478 | 71 | 15 | 0 |
| 30 Sep 17 | 473 | 70 | 16 | 0 |
| 30 Jun 17 | 473 | 70 | 16 | 0 |
| 31 Mar 17 | 472 | 70 | 16 | 0 |
| 31 Dec 16 | 474 | 70 | 16 | 0 |
| 30 Sep 16 | 470 | 71 | 16 | 0 |
| 30 Jun 16 | 452 | 71 | 15 | 0 |
| 31 Mar 16 | 432 | 70 | 14 | 0 |
| 31 Dec 15 | 411 | 69 | 13 | 0 |
| 30 Sep 15 | 396 | 69 | 11 | 0 |
| 30 Jun 15 | 389 | 68 | 11 | 0 |
| 31 Mar 15 | 382 | 68 | 10 | 0 |
| 31 Dec 14 | 375 | 68 | 10 | 0 |
| 30 Sep 14 | 363 | 89 | 9 | 0 |
| 30 Jun 14 | 353 | 87 | 9 | 0 |
| 31 Mar 14 | 347 | 86 | 9 | 0 |
| 31 Dec 13 | 341 | 85 | 9 | 0 |
| 30 Sep 13 | 336 | 62 | 8 | 0 |
| 30 Jun 13 | 330 | 61 | 8 | 0 |
양질의 수익: BSL 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: BSL 의 현재 순이익 이익률 (12.7%) 작년보다 낮습니다 (17.4%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: BSL 의 수입은 지난 5년 동안 매년 17.7% 씩 증가했습니다.
성장 가속화: BSL 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: BSL 은 지난 1년 동안 마이너스 수익 성장( -37.1% )을 기록하여 Healthcare 업계 평균( -9% ).
자기자본 수익률
높은 ROE: BSL 의 자본 수익률( 8.7% )은 낮음으로 간주됩니다.